Question 1

What are the potential side effects of XNW28012?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my participation involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to be in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks I should be aware of before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer clinical trial (NCT07707674). Contact the study team or your healthcare provider for specific answers.

What this study is about